Study title: A Randomized, Double-Blind, Placebocontrolled, Multicenter, Parallel-Arm Study Assessing the Efficacy, Safety, and Doseresponse of Ramipril for the Treatment of Hypertension in Children and Adolescents
Type of medicine: Medicines containing chemical active substances | |||||
Therapeutic area: Cardiovascular Diseases | |||||
Brands: Please see report | |||||
MAH holders: Please see report | |||||
Assessment: | |||||
Active substance: RAMIPRIL | |||||
ATC code: | |||||
Document link: Ramipril-Study 2.pdf | |||||
Document date: 2011-09-06 | |||||
Study number: K726-06-4003 | |||||
EudraCT number: | |||||
Scope of study: Clinical | |||||
Population of study subjects: | Preterm newborn Infants | Newborn infants (1 to 27 days) | Infants and toddlers (28 days to 24 months) | Children (2 to 11 years) | Adolescents (12 to 18 years) |
- | - | - | Y | Y |